Letters Varenicline and suicide Authors’ reply BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4969 (Published 01 December 2009) Cite this as: BMJ 2009;339:b4969 Article Related content Metrics Responses Peer review Related articles Paper Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study Published: 17 February 2005; BMJ 330 doi:10.1136/bmj.330.7488.389 Research Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database Published: 01 October 2009; BMJ 339 doi:10.1136/bmj.b3805 See more Maternal deaths from suicide must be tackled, say experts BMJ December 07, 2016, 355 i6585; DOI: https://doi.org/10.1136/bmj.i6585 Dyspnoea after home improvement work BMJ November 30, 2016, 355 i5957; DOI: https://doi.org/10.1136/bmj.i5957 Risks of duloxetine for stress incontinence outweigh benefits, say researchers BMJ November 15, 2016, 355 i6103; DOI: https://doi.org/10.1136/bmj.i6103 Health professionals’ stereotyping is impeding suicide prevention efforts BMJ November 11, 2016, 355 i6072; DOI: https://doi.org/10.1136/bmj.i6072 Action is urged to improve physical health in severe mental illness BMJ October 25, 2016, 355 i5729; DOI: https://doi.org/10.1136/bmj.i5729 Cited by... Safety data from New ZealandFulltext
